The effect of underweight on the effective dose of propofol for successful insertion of gastroscope in young female patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063625

Enrollment

Unknown

Registered

2022-09-13

Start date

2022-09-13

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Underweight group:Propofol

Normal weight group:Propofol

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective painless gastroscopy; 2. Underweight (BMI<18.5kg/m2) and normal body weight (18.5=BMI<25 kg/m2) Patients; 3. Female aged 18-35; 4. American Society of Anesthesiologists (ASA) physical status classification I-II; 5. Patients who fully understood the contents of the informed consent form and signed the informed consent form before the study.

Exclusion criteria

Exclusion criteria: 1. Allergic to propofol; 2. General anesthetics, sedatives or analgesics were used within two weeks before gastroscopy; 3. Patients with upper airway disease, such as airway occupying, a history of upper respiratory tract infection within two weeks; 4. Pregnancy or lactation; 5. Patients with difficult airway; 6. Patients with abnormal liver and kidney functions; 7. Patients who refuse to participate in this study; 8. Other situations not suitable for participation considered by researchers in this study.

Design outcomes

Primary

Measure	Time frame
effective dose of propofol;	—

Countries

China

Contacts

Public ContactZhu Qian

Beijing Friendship Hospital, Capital Medical University

zhuqianyyyy@163.com+86 10 6313 8761

Outcome results